Cargando…

Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children

Objective. Graves' disease is the most common cause of hyperthyroidism in the pediatric population. Antithyroid medications used in children and adults include propylthiouracil (PTU) and methimazole (MMI). At our center we have routinely used MMI for Graves' disease therapy. Our goals are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivkees, Scott A., Stephenson, Kerry, Dinauer, Catherine
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833412/ https://www.ncbi.nlm.nih.gov/pubmed/20224800 http://dx.doi.org/10.1155/2010/176970

Ejemplares similares

Incidence of vitiligo in children with Graves' disease and Hashimoto's thyroiditis
por: Prindaville, Brea, et al.
Publicado: (2011)

Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
por: Lee, Hyun Gyung, et al.
Publicado: (2021)

Long-term methimazole therapy in Graves’ hyperthyroidism and adverse reactions: a Danish multicenter study
por: Karmisholt, J, et al.
Publicado: (2022)

Methimazole-Induced Pleural Effusion in the Setting of Graves' Disease
por: Khine, Le Yu, et al.
Publicado: (2019)

Effect of patient Age on surgical outcomes for Graves’ disease: a case–control study of 100 consecutive patients at a high volume thyroid surgical center
por: Breuer, Christopher K, et al.
Publicado: (2013)

Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2020)

Polyarthritis Caused by Methimazole in Two Japanese Patients with Graves’ Disease
por: Nihei, Hiroko, et al.
Publicado: (2013)

Myopathy Associated with Acute Hypothyroidism following Radioiodine Therapy for Graves Disease in an Adolescent
por: Benavides, Valeria C., et al.
Publicado: (2010)

Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves' Hyperthyroidism: A Randomized Controlled Study
por: Sriussadaporn, Sutin, et al.
Publicado: (2017)

Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease
por: Roh, Eun, et al.
Publicado: (2013)

SUN-517 Methimazole-Induced Neutropenia in Premature Twins with Graves’ Disease
por: Ballestas, Estefania Rodriguez, et al.
Publicado: (2020)

A Rare Case of Anaphylaxis to Methimazole in a Patient With Graves’ Disease
por: Garg, Dave, et al.
Publicado: (2021)

Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease
por: Schneider Aguirre, Rebecca, et al.
Publicado: (2021)

Antithyroid arthritis syndrome caused by methimazole in a patient with Graves’ disease
por: Kawasumi, Muneo, et al.
Publicado: (2023)

Pediatric Graves’ disease: management in the post-propylthiouracil Era
por: Rivkees, Scott A
Publicado: (2014)

Chylous Ascites: A Rare Adverse Effect of Methimazole Treatment for Grave's Disease—A Case Report and Review of the Literature
por: Khoury, Tawfik, et al.
Publicado: (2015)

Insulin autoimmune syndrome induced by methimazole in a Korean girl with Graves' disease
por: Lee, Sun Hee, et al.
Publicado: (2013)

Impact of Methimazole Treatment on Magnesium Concentration and Lymphocytes Activation in Adolescents with Graves’ Disease
por: Klatka, Maria, et al.
Publicado: (2013)

Low-Dose Dexamethasone Therapy from Infancy of Virilizing Congenital Adrenal Hyperplasia
por: Rivkees, Scott A., et al.
Publicado: (2009)

FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
por: Barua, Nabonita, et al.
Publicado: (2023)

Initial Treatment of Pediatric Graves’ Disease with Methimazole: A Retrospective Follow-up Study
por: Matsushita, Rie, et al.
Publicado: (2010)

Delayed methimazole-induced agranulocytosis in a 6-year old patient with Graves’ disease
por: Puthenpura, Vidya, et al.
Publicado: (2016)

Evaluating the Role of Circulating Dendritic Cells in Methimazole-Treated Pediatric Graves’ Disease Patients
por: Starosz, Aleksandra, et al.
Publicado: (2021)

Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves’ Disease
por: Wijaya, Natalia, et al.
Publicado: (2019)

THU669 Time To Achieve Euthyroidism In Graves Disease Using Methimazole In An Urban Population
por: Sultana Habbsa, Samima, et al.
Publicado: (2023)

A Case of Hypocalcemia with Severe Vitamin D Deficiency following Treatment for Graves' Disease with Methimazole
por: Miyashita, Kazuyuki, et al.
Publicado: (2013)

Very rare case of Graves’ disease with resistance to methimazole: a case report and literature review
por: Mori, Yusaku, et al.
Publicado: (2021)

Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves’ Disease Before and After Methimazole Treatment
por: Yang, Mengxue, et al.
Publicado: (2022)

Different doses of methimazole treatment of children and adolescents with graves’ disease: a clinical study based on 161 cases of outpatients
por: Li, Peng, et al.
Publicado: (2023)

Agranulocytosis with tonsillitis associated with methimazole therapy
por: Zambrana, Jorge T., et al.
Publicado: (2015)

Erratum to: Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease
Publicado: (2021)

Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature
por: Yang, Jun, et al.
Publicado: (2015)

Clinical effect of methimazole combined with selenium in the treatment of toxic diffuse goiter in children
por: Zhang, Xiao-Hong, et al.
Publicado: (2022)

Vaccination-associated cardiac adverse events rare
Publicado: (2022)

Adverse events related with propylthiouracil therapy of Graves’ Disease in children at Cipto Mangunkusumo Hospital Jakarta
por: Andriana, Novina, et al.
Publicado: (2013)

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
por: Eguchi, Hiroyuki, et al.
Publicado: (2015)

Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
por: Azizi, Fereidoun, et al.
Publicado: (2021)

Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013
por: Hwang, Sun Mi, et al.
Publicado: (2016)

SAT-625 Dose-Dependent, Methimazole-Induced Agranulocytosis in a Pregnant Hispanic Woman with Grave's Disease
por: Bello, Fatimah, et al.
Publicado: (2019)

Methimazole-induced insulin autoimmune syndrome in Graves' disease with hypokalemia: A case report and literature review
por: Han, Rongfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cobp58vie1jqntoi2ajoh8iu3l